Brixadi multiple strengths in weekly and monthly formulations Images
Generic Name: buprenorphine
This medication has been identified as Brixadi multiple strengths in weekly and monthly formulations. It is supplied by Braeburn, Inc.
Brixadi is used in the treatment of Opiate Dependence - Maintenance; Opioid Use Disorder. Risk cannot be ruled out during pregnancy. Brixadi multiple strengths in weekly and monthly formulations is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images of medication
Brixadi
- Generic Name
- buprenorphine
- Strength
- multiple strengths in weekly and monthly formulations
- Availability
- Prescription only
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Braeburn, Inc.
- National Drug Code (NDC)
More about Brixadi (buprenorphine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Breastfeeding
Patient resources
Other brands
Belbuca, Subutex, Sublocade, Butrans, ... +2 more
Professional resources
Other brands
Belbuca, Sublocade, Butrans, Buprenex, Probuphine
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
